Article Versions Notes

Kroeze SGC, Fritz C, Schaule J, Blanck O, Kahl KH, Kaul D, Siva S, Gerum S, Claes A, Sundahl N, et al. Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis. Cancers. 2021; 13(19):4780. https://doi.org/10.3390/cancers13194780

Kroeze, Stephanie G. C., Corinna Fritz, Jana Schaule, Oliver Blanck, Klaus Henning Kahl, David Kaul, Shankar Siva, Sabine Gerum, An Claes, Nora Sundahl, and et al. 2021. "Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis" Cancers 13, no. 19: 4780. https://doi.org/10.3390/cancers13194780

Kroeze, S. G. C., Fritz, C., Schaule, J., Blanck, O., Kahl, K. H., Kaul, D., Siva, S., Gerum, S., Claes, A., Sundahl, N., Adebahr, S., Stera, S., Schymalla, M. M., Abbasi-Senger, N., Buergy, D., Geier, M., Szuecs, M., Lohaus, F., Henke, G., ... Guckenberger, M. (2021). Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis. Cancers, 13(19), 4780. https://doi.org/10.3390/cancers13194780